期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
新型肝胆显影剂配体-MEBROFENIN((艹米)溴氨乙酸)及其类似物的合成
1
作者 刘春祥 杜东里 +2 位作者 冉祥凯 宫莲珍 张志华 《中国生化药物杂志》 CAS CSCD 1993年第3期32-33,共2页
通过溴化、成酐、氨解等反应,合成了新型肝胆显影剂配体-莱溴氨乙酸及其四个未见报道的类似物。
关键词 肝胆显影剂 Mi溴氨乙酸 mebrofenin
下载PDF
^(99)Tc^m-mebrofenin肝胆显像诊断胆道闭锁的价值 被引量:3
2
作者 赵瑞芳 曾纪骅 +3 位作者 肖现民 贾宏丽 季志英 袁虹 《中华核医学杂志》 CAS CSCD 北大核心 2000年第1期28-28,共1页
关键词 胆道闭锁 肝胆显像 诊断^99Tc^m mebrofenin
下载PDF
肝胆能对肝脏分泌放射性肝胆显像剂的影响 被引量:2
3
作者 陈绍亮 修雁 +1 位作者 孙晓光 李文罡 《核技术》 EI CAS CSCD 北大核心 1998年第11期680-682,共3页
为了解肝胆能(Galle-Donau)中两种主要成分α—NAA和NTMC的药理作用和它对肝胆动力学的影响,将60只小鼠分为3组,分别灌胃α—NAA10mg、NTMC10mg和生理盐水0.2mL,紧接着各自静脉注射99m-Tc-甲溴菲宁(Mebrofenin)370kBq。分别于5... 为了解肝胆能(Galle-Donau)中两种主要成分α—NAA和NTMC的药理作用和它对肝胆动力学的影响,将60只小鼠分为3组,分别灌胃α—NAA10mg、NTMC10mg和生理盐水0.2mL,紧接着各自静脉注射99m-Tc-甲溴菲宁(Mebrofenin)370kBq。分别于5、15、30、60min处死后测放射性。α—NAA组30min后、NTMC组5min后表现出胆汁分泌增加,放射量明显增加。提示肝胆能对肝脏动力学影响明显。 展开更多
关键词 动力学 放射性药物 动物实验 显像剂 肝胆能
下载PDF
^(99m)Tc-标记新肝胆显象剂的合成和动物实验 被引量:1
4
作者 周锡瑞 陈绍亮 +1 位作者 陈国辉 徐勤丰 《上海医科大学学报》 CSCD 1993年第5期333-337,T017,共6页
为寻找较胆红素竞争能力更强,肝胆显象更为清晰的放射性显象剂,作者根据构效关系原理,设计合成6个化合物。与临床应用的^(99m)Tc-Etifenin和更佳的^(99m)Tc-甲溴苯宁配对进行初步动物筛选,6个化合物的结果均优于^(99m)Tc-Etifenin,类似... 为寻找较胆红素竞争能力更强,肝胆显象更为清晰的放射性显象剂,作者根据构效关系原理,设计合成6个化合物。与临床应用的^(99m)Tc-Etifenin和更佳的^(99m)Tc-甲溴苯宁配对进行初步动物筛选,6个化合物的结果均优于^(99m)Tc-Etifenin,类似于^(99m)Tc-甲溴苯宁。 展开更多
关键词 肝胆显象剂 吡哆氨基酸 甲溴苯宁
下载PDF
Hepatobiliary scintigraphy for detecting biliary strictures after living donor liver transplantation 被引量:6
5
作者 Yu Jin Kim Kyu Taek Lee +4 位作者 Young Cheol Jo Kwang Hyuck Lee Jong Kyun Lee Jae-Won Joh Choon Hyuck David Kwon 《World Journal of Gastroenterology》 SCIE CAS CSCD 2011年第21期2626-2631,共6页
AIM:To investigate the diagnostic accuracy of hepatobiliary scintigraphy(HBS) in detecting biliary strictures in living donor liver transplantation(LDLT) patients.METHODS:We retrospectively reviewed 104 adult LDLT rec... AIM:To investigate the diagnostic accuracy of hepatobiliary scintigraphy(HBS) in detecting biliary strictures in living donor liver transplantation(LDLT) patients.METHODS:We retrospectively reviewed 104 adult LDLT recipients of the right hepatic lobe with duct-toduct anastomosis,who underwent HBS and cholangiography.The HBS results were categorized as normal,parenchymal dysfunction,biliary obstruction,or bile leakage without re-interpretation.The presence of biliary strictures was determined by percutaneous cholangiography or endoscopic retrograde cholangiopancreatography(ERCP).RESULTS:In 89 patients with biliary strictures,HBS showed biliary obstruction in 50 and no obstruction in 39,for a sensitivity of 56.2%.Of 15 patients with no biliary strictures,HBS showed no obstruction in 11,for a specificity of 73.3%.The positive predictive value(PPV) was 92.6%(50/54) and the negative predictive value(NPV) was 22%(11/50).We also analyzed the diagnostic accuracy of the change in bile duct size.The sensitivity,NPV,specificity,and PPV were 65.2%,27.9%,80% and 95%,respectively.CONCLUSION:The absence of biliary obstruction on HBS is not reliable.Thus,when post-LDLT biliary strictures are suspected,early ERCP may be considered. 展开更多
关键词 肝移植 胆道 狭窄 肝脏 活体 检测 显像 功能障碍
下载PDF
Liver venous deprivation versus portal vein embolization before major hepatectomy:future liver remnant volumetric and functional changes 被引量:12
6
作者 Boris Guiu François Quenet +9 位作者 Fabrizio Panaro Lauranne Piron Christophe Cassinotto Astrid Herrerro François-Régis Souche Margaux Hermida Marie-Ange Pierredon-Foulongne Ali Belgour Serge Aho-Glele Emmanuel Deshayes 《Hepatobiliary Surgery and Nutrition》 SCIE 2020年第5期564-576,共13页
Background:We previously showed that embolization of portal inflow and hepatic vein(HV)outflow(liver venous deprivation,LVD)promotes future liver remnant(FLR)volume(FLR-V)and function(FLR-F)gain.Here,we compared FLR-V... Background:We previously showed that embolization of portal inflow and hepatic vein(HV)outflow(liver venous deprivation,LVD)promotes future liver remnant(FLR)volume(FLR-V)and function(FLR-F)gain.Here,we compared FLR-V and FLR-F changes after portal vein embolization(PVE)and LVD.Methods:This study included all patients referred for liver preparation before major hepatectomy over 26 months.Exclusion criteria were:unavailable baseline/follow-up imaging,cirrhosis,Klatskin tumor,two-stage hepatectomy.99mTc-mebrofenin SPECT-CT was performed at baseline and at day 7,14 and 21 after PVE or LVD.FLR-V and FLR-F variations were compared using multivariate generalized linear mixed models(joint modelling)with/without missing data imputation.Results:Baseline FLR-F was lower in the LVD(n=29)than PVE group(n=22)(P<0.001).Technical success was 100%in both groups without any major complication.Changes in FLR-V at day 14 and 21(+14.2%vs.+50%,P=0.002;and+18.6%vs.+52.6%,P=0.001),and in FLR-F at day 7,14 and 21(+23.1%vs.+54.3%,P=0.02;+17.6%vs.+56.1%,P=0.006;and+29.8%vs.+63.9%,P<0.001)differed between PVE and LVD group.LVD(P=0.009),age(P=0.027)and baseline FLR-V(P=0.001)independently predicted FLR-V variations,whereas only LVD(P=0.01)predicted FLR-F changes.After missing data handling,LVD remained an independent predictor of FLR-V and FLR-F variations.Conclusions:LVD is safe and provides greater FLR-V and FLR-F increase than PVE.These results are now evaluated in the HYPERLIV-01 multicenter randomized trial. 展开更多
关键词 Portal vein embolization(PVE) liver venous deprivation(LVD) RESECTION HEPATECTOMY mebrofenin
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部